Extra cleaning has been introduced at Dumfries and Galloway’s main hospital in a bid to tackle infections. Officials say ...
Referral to an infectious disease physician was the only modifiable strategy to reduce 28-day mortality among adults presenting to the ED with bacteremia.
Fog is a common, natural occurrence that has a variety of possible sources. Most often in Florida, it happens when either ...
improves 30-day clinical outcomes in patients hospitalized with Enterobacterales bacteremia. “Starting early PDAT may be important not only for antimicrobial stewardship but also for improving ...
Sanofi SA (NASDAQ:SNY) and Johnson & Johnson (NYSE:JNJ) have discontinued the E.mbrace phase 3 study evaluating a vaccine ...
As you brush and floss, remember, your gums aren’t just a matter of dental concern; they may hold the key to your overall ...
1d
News Medical on MSNDiabetes fuels antibiotic resistance, worsening infections and treatment challengesA new study reveals that diabetes significantly accelerates the emergence and spread of antibiotic-resistant Staphylococcus ...
Sanofi and Johnson & Johnson’s E. coli vaccine candidate failed to prevent invasive E. coli disease effectively.
Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study Independent interim analysis of the E.mbrace phase 3 study finds that the vaccine candidate didn’t demonstrate sufficient ...
Orca-T with reduced-intensity stem cell transplantation was a safe, feasible alternative to conventional transplant in blood ...
A scheduled review of the E.mbrace phase 3 study (clinical trial identifier: NCT04899336) conducted by an independent data monitoring committee (IDMC) determined that Sanofi and Johnson & Johnson’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results